跳至主要内容
临床试验/NCT02833909
NCT02833909已完成不适用

ex Vivo Study of the Inflammatory Response Associated With Hidradenitis Suppurativa

CHU de Reims2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
CHU de Reims
入组人数
20
试验地点
2
主要终点
cytokine quantification (IL-10) by ELISA

研究概览

简要总结

The objective is to investigate ex vivo the inflammatory response in hidradenitis suppurativa (HS) (activation of an inflammasome, role of pro-inflammatory cytokines) in the skin of patients treated surgically for this disease.

The investigators hypothesize that Th17-derived cytokines, especially Interleukin (IL) IL-17, could serve as a relay in the inflammatory process leading to HS severity and recurrences.

详细描述

The objective is to investigate ex vivo the inflammatory response in hidradenitis suppurativa (activation of an inflammasome, role of pro-inflammatory cytokines) in the skin of patients treated surgically for this disease.

The investigators hypothesize that Th17-derived cytokines, especially IL-17, could serve as a relay in the inflammatory process leading to HS severity and recurrences.To fulfil this proposal, the investigators will aim at demonstrating and characterizing the presence of an inflammasome associated to HS disease - Hypothesis It is widely accepted that hyperkeratinisation and follicular occlusion originate infection thereof causing skin inflammation. The investigators here hypothesized that host-derived danger signals led to the release of inflammatory mediators such as IL-1β by activating an inflammasome structure.

The inflammasome is a molecular platform controlling the expression and the activation of IL-1β via different sensors. The proinflammatory cytokine IL-1β could subsequently lead to the recruitment and orientation of lymphocytes towards a Th17 subtype creating a feedback loop maintaining excessive tissue inflammation in HS.

If such a complex inflammatory process is present in HS, blocking both the bacterial-induced (IL-1 β) and the sterile-associated (IL-17) inflammation would largely improve the therapeutic benefit for HS patients.

- Experimental approach

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with moderate to severe HS in the Dermatology department of Reims CHU, and eligible for surgery
  • Patients accepting to participate to the study (signed consent)
  • Patients affiliated to a certain social scheme
  • Controls with plastic surgery but without HS, affiliated to a certain social scheme and accepting to participate

排除标准

  • Patients <18yo

结局指标

主要结局

cytokine quantification (IL-10) by ELISA

时间窗: up to 4 days

cytokines quantification (CXCL10) by ELISA

时间窗: up to 4 days

cytokines quantification (TNFα) by ELISA

时间窗: up to 4 days

cytokine quantification (IL1-β) by ELISA

时间窗: up to 4 days

cytokines quantification (IL-13) by ELISA

时间窗: up to 4 days

cytokines quantification (IL-18) by ELISA

时间窗: up to 4 days

cytokines quantification (TGFβ) by ELISA

时间窗: up to 4 days

次要结局

未报告次要终点

研究者

发起方
CHU de Reims
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验